Valuation: DocMorris AG

Market Cap 52Cr 63Cr 55Cr 48Cr 89Cr 6.05TCr 91Cr 613.93Cr 240.09Cr 2.99TCr 236.99Cr 231.85Cr 10TCr P/E 2026 *
-6.76x
P/E 2027 * -13.5x
Enterprise Value 72Cr 88Cr 77Cr 66Cr 123.32Cr 8.38TCr 126.36Cr 851.2Cr 332.88Cr 4.15TCr 328.59Cr 321.45Cr 14TCr EV / Sales 2026 *
0.58x
EV / Sales 2027 * 0.54x
Free-Float
64.09%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 63Cr
-1.80%+4.75%-21.83%-30.23% 1.63TCr
-1.67%+2.92%-28.83%-36.05% 739.9Cr
-2.01%+7.98%-15.26%-4.82% 646.18Cr
+1.02%+4.32%-4.82%-29.25% 406.46Cr
+1.32%+5.21%-22.10%-45.51% 327.9Cr
+0.74%+1.17%+9.08%-32.36% 319.23Cr
0.00%-1.35%-41.74%-23.50% 301.74Cr
+2.65%+7.10%-9.89%+5.73% 271.65Cr
-2.08%+3.07%+101.62% - 259.55Cr
Average -9.04%+4.52%-3.75%-24.50% 544.36Cr
Weighted average by Cap. -1.98%+5.35%-12.64%-26.22%

Financials

2026 *2027 *
Net sales 123.68Cr 150.79Cr 132.5Cr 113.51Cr 212.47Cr 14TCr 217.71Cr 1.47TCr 573.55Cr 7.15TCr 566.15Cr 553.86Cr 25TCr 138.89Cr 169.34Cr 148.8Cr 127.47Cr 238.61Cr 16TCr 244.49Cr 1.65TCr 644.09Cr 8.03TCr 635.78Cr 621.98Cr 28TCr
Net income -8.1Cr -9.88Cr -8.68Cr -7.43Cr -14Cr -946.01Cr -14Cr -96Cr -38Cr -468.13Cr -37Cr -36Cr -1.62TCr -4.37Cr -5.33Cr -4.68Cr -4.01Cr -7.5Cr -510.05Cr -7.69Cr -52Cr -20Cr -252.39Cr -20Cr -20Cr -872.52Cr
Net Debt 20Cr 24Cr 21Cr 18Cr 34Cr 2.34TCr 35Cr 237.27Cr 93Cr 1.16TCr 92Cr 90Cr 4TCr 24Cr 29Cr 25Cr 22Cr 41Cr 2.76TCr 42Cr 279.81Cr 109.43Cr 1.36TCr 108.01Cr 105.67Cr 4.71TCr
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.59CHF
Average target price
10.22CHF
Spread / Average Target
-3.51%

Quarterly revenue - Rate of surprise